Investigator's Brochure (IB) Table
Drugs
| Drug Name | Drug Company Sort descending | IB Date | Risk List Available? |
|---|---|---|---|
| ABT-267, ABT 333, ABT-450 and Ritonavir | AbbVie | June 2017 | |
| Glecaprevir (ABT-493) and Pibrentasvir (ABT-530) | AbbVie | December 2018 | |
| Cenicriviroc Mesylate CVC (TBR-652) - New | Allergan | March 2020 | |
| Tenofovir Gel | CONRAD | January 2013 | |
| Tenofovir Vaginal Ring | CONRAD | August 2017 | |
| Tenofovir Alafenamide/Elvitegravir | CONRAD | July 2019 | |
| Sofosbuvir/Velapatasvir (Epclusa) | Gilead | July 2016 | |
| Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) | Gilead Sciences | December 2016 | YES |
| Dapivirine (Microbicide Gel) | International Partnership for Microbicides | May 2017 | |
| Dapivirine (Vaginal Ring) | International Partnership For Microbicides | November 2019 | |
| Rilpivirine (TMC278, Edurant) | Janssen Research & Development | July 2019 | |
| Bedaquiline (TMC207) | Janssen Research & Development | February 2019 | |
| Etravirine (TMC125, Intelence) | Janssen Research & Development | November 2019 | |
| Vorinostat (Zolinza) | Merck | August 2013 | |
| Doravirine (MK-1439) | Merck | January 2020 | |
| Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) | Merck | January 2020 | |
| Raltegravir (Isentress) | Merck | September 2017 | YES |
| Delamanid (OPC-67683) | Otsuka | April 2019 | |
| PC-1005 | Population Council | April 2017 | |
| Cemiplimab (REGN2810) | Regeneron Pharmaceuticals, Inc. | May 2019 |
Vaccines
| Vaccine Name | Vaccine Company | IB Date | Risk List Available? |
|---|---|---|---|
| RV460 (ALF43) - New | DAIDS/NIAID/NIH | February 2020 | |
| N-803 - New | Altor BioScience | April 2019 | |
| Hepatitis B Vaccine Recombinant, Adjuvanted (Heplisav-B) | Dynavax Technologies Corporation | August 2019 | |
| PGT121.414.LS (VRC-HIVMAB0107-00-AB) | VCMP/NIAID/NIH | October 2019 | |
| BG505 SOSIP.664 gp140 | DAIDS/NIAID/NIH | October 2019 | |
| MPER-656 Liposomes with Aluminum Hydroxide Suspension | DAIDS/NIAID/NIH | February 2019 | |
| PGDM1400 | Beth Israel Deaconess Medical Center | August 2018 | |
| PGT121 | Beth Israel Deaconess Medical Center | January 2019 | |
| RSV 6120/DeltaNS2/1030s | LID/NIAID/NIH | March 2019 | |
| CH505TF gp120 Transient | DAIDS/NIAID/NIH | December 2018 | |
| GEO-D02 and MVA-HIV62B Vaccine | GeoVax | June 2019 | |
| SAR441236 | Sanofi | June 2018 | |
| 10-1074 | Rockefeller University/Mass Biologics | September 2019 | |
| PDPHV-201401 | Laboratory of Nucleic Acid Vaccines (LNAV) | October 2017 | |
| ALVAC-HIV (vCP2438) | Sanofi Pasteur | August 2017 | |
| AIDSVAX B/E | Global Solutions for Infectious Diseases | March 2016 | |
| Ad26.ENVA.01 | Crucell Holland BV | June 2013 | |
| Recombinant oligomeric gp145 C.6980 Clade C HIV Env protein | NIH/NIAID | August 2017 | |
| RSV 276 | LID/NIAID/NIH | February 2019 | |
| Bivalent Subtype C gp120 with Aluminum Hydroxide Adjuvant | NIAID/NIH | June 2015 |